Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacs (PACS) Share-based Compensation (2024 - 2026)

Pacs recorded quarterly Share-based Compensation of $20.3 million in Q1 2026, up 29.22% quarter-over-quarter from $15.7 million in Q4 2025, and up 66.76% year-over-year from $12.2 million in Q1 2025.

Pacs' Share-based Compensation history runs 3 years deep, the most recent figure standing at $20.3 million for Q1 2026.

  • In Q1 2026, Share-based Compensation rose 66.76% year-over-year to $20.3 million; the TTM figure through Mar 2026 stood at $62.2 million (down 51.3% YoY), while the FY2025 annual figure was $54.1 million, down 53.2% from the prior year.
  • Share-based Compensation came in at $20.3 million for Q1 2026 at Pacs, up from $15.7 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $90.9 million in Q2 2024 to a low of $12.2 million in Q1 2025.
  • A 3-year average of $23.7 million and a median of $13.1 million in 2025 frame the typical range for Share-based Compensation.
  • Across the five-year window, Share-based Compensation tumbled 85.04% in 2025 and surged 66.76% in 2026, its largest moves.
  • Pacs' Share-based Compensation stood at $12.3 million in 2024, then rose by 27.98% to $15.7 million in 2025, then gained by 29.22% to $20.3 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $20.3 million, $15.7 million, and $12.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn 86.00 Mn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 25.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 28.16 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 11.50 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn 13.90 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn 22.50 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn -
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 9.25 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn 20.35 Mn
10 Option Care Health 3.27 Bn 3.09 Bn 262.01 Mn 10.20 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 20.35 Mn
Mar 31, 2026 20.35 Mn
Dec 31, 2025 15.75 Mn
Dec 31, 2025 15.75 Mn
Sep 30, 2025 12.52 Mn
Sep 30, 2025 12.52 Mn
Jun 30, 2025 13.60 Mn
Jun 30, 2025 13.60 Mn
Mar 31, 2025 12.20 Mn
Mar 31, 2025 12.20 Mn
Dec 31, 2024 12.30 Mn
Dec 31, 2024 12.30 Mn
Sep 30, 2024 12.30 Mn
Sep 30, 2024 12.30 Mn
Jun 30, 2024 90.94 Mn
Jun 30, 2024 90.94 Mn